Clinical trial
An Observational Study on the Identification of Prescription Patterns of STAFEN Cap., Changes in Blood Lipid Concentration, and Statin-related Muscle Symptoms in Korean Patients With Mixed Dyslipidemia
NCT06204380 is registered in ClinicalTrials.gov with Hanlim Pharm. Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study on the Identification of Prescription Patterns of STAFEN Cap., Changes in Blood Lipid Concentration, and Statin-related Muscle Symptoms in Korean Patients With Mixed Dyslipidemia
- Lead sponsor
- Hanlim Pharm. Co., Ltd.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 21, 2021
- Completion date
- November 30, 2024
- Enrollment
- 4,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mixed dyslipidemia